Info doc for Admission of New Shares EU 2017/1129
Summary by AI BETAClose X
Information Document pursuant to Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (Article 1(4)(i) and Article 1(5)(h)) in connection with the issuance and admission to trading of new ordinary registered shares of METLEN ENERGY & METALS PLC.
METLEN ENERGY & METALS PLC (the "Company") hereby informs the investing public, pursuant to the provisions of Article 1(4)(i) and Article 1(5)(h) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, as amended, in connection with the admission to trading on the Main Market of the London Stock Exchange plc (the "LSE") (the "London Admission") and on a secondary admission to trading on Euronext Athens Holding SA ("Euronext Athens") (the "Euronext Athens Admission" and, together with the London Admission, the "Admission"), of four hundred and three thousand two hundred and sixty-four (403,264) new ordinary registered shares of the Company, each of a nominal value of one euro (€1.00) (the "New Ordinary Shares"), to selected employees and members of the Board of Directors of the Company and its subsidiaries (the "Beneficiaries").
The New Ordinary Shares will be issued in connection with the implementation of the stock award program approved by the Meeting of the Board of Directors held on 24 June 2025 (the "Stock Award Program"), which constitutes a share incentive arrangement for the benefit of selected employees and senior executives of the Company and its subsidiaries. The New Ordinary Shares will be allotted to the Beneficiaries of the Stock Award Program through an employee benefit trust ("EBT") structure, which operates alongside the Stock Award Program as a vehicle. The purpose of the Stock Award Program is to reward the performance and contribution of the Beneficiaries towards the achievement of the Company's strategic objectives and to promote the retention, motivation, and attraction of talented and capable executives, thereby serving and ensuring the long-term interests and sustainability of the Company and its affiliates.
The New Ordinary Shares were issued by way of a share capital increase for cash consideration, which was approved by a resolution of the Board of Directors of the Company dated 16 June 2026, following a resolution of the Remuneration Committee of the Company dated 16 June 2026, pursuant to which the establishment and funding of the EBT were approved. The New Ordinary Shares are of the same class and carry the same rights as the existing ordinary shares of the Company, which have already been admitted to trading on LSE and on Euronext Athens.
Pursuant to the aforesaid resolution, the New Ordinary Shares will be allotted to a total of 76 Beneficiaries.
Following the above share capital increase, the share capital of the Company will amount to one hundred and forty-three million four hundred and twenty-six thousand two hundred and forty-four euros (€143,426,244), divided into one hundred and forty-three million four hundred and twenty-six thousand two hundred and forty-four (143,426,244) registered shares each of a nominal value of one euro (€1.00).
The Company will follow the procedure for the listing of the New Ordinary Shares to trading on Euronext Athens in accordance with the Euronext Athens Rulebook and the relevant resolutions of the Board of Directors of Euronext Athens. The opening price of the Company's shares on Euronext Athens on the day of commencement of trading will be determined in accordance with the Euronext Athens Rulebook and Decision No. 26 of the Board of Directors of Euronext Athens, as in force from time to time. As of the commencement date of trading, the New Ordinary Shares will be registered in the records of the Greek Central Securities Depository (ATHEXCSD) and in the accounts held by the Beneficiaries in the Dematerialized Securities System (D.S.S.) of Euronext Athens, in accordance with applicable law.
The date of commencement of trading of the New Ordinary Shares will be 23.06.2026. A relevant announcement will be posted on the Euronext Athens website no later than the business day of commencement of trading.
Pursuant to Article 1(4)(i) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, as amended, no obligation arises to publish a prospectus in connection with the distribution of the New Ordinary Shares, on the basis that this information document includes information regarding the number and nature of the securities being distributed, together with the reasons for and details of the distribution.
Pursuant to Article 1(5)(h) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, as amended, no obligation arises to publish a prospectus in connection with the admission to trading on a regulated market, on the basis that the New Ordinary Shares are of the same class as shares of the Company already admitted to trading on the same regulated market, and this information document includes information regarding the number and nature of the new shares being admitted to trading, together with the reasons for and details of the distribution.
The person responsible for the preparation of this information document and for the accuracy of the information contained herein on behalf of the Company is the Investor Relations Department - Shareholder Services of the Company (ir@metlen.com and (+30) 210 6877436).
This Information Document is available to interested parties in hard copy at the registered office of the Company and in electronic form on the Company's website at www.metlen.com.
Maroussi, 19 June 2026
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 53 seconds ago QinetiQ Group
- 22 minutes ago JPMorgan Emerging Markets Growth & Income plc
- 24 minutes ago National Grid
- 1 hour ago City of London Investment Group
- 1 hour ago BioPharma Credit